InHandPlus is developing solutions to improve the way we take our prescribed medications.
InHandPlus has raised $2.3M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
InHandPlus's investors include Strong Ventures, TIPS Program, Genaxis, IPS Ventures, Maple Investment Partners.
InHandPlus is headquartered in Yeoksamdong, South Korea.
InHandPlus is developing solutions to improve the way we take our prescribed medications.
InHandPlus is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InHandPlus — Funding & Investors." VCBacked, July 10, 2023, https://www.vcbacked.co/company/inhandplus. Accessed July 19, 2026.
VCBacked. (2023). InHandPlus — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/inhandplus
{{cite web |title=InHandPlus — Funding & Investors |url=https://www.vcbacked.co/company/inhandplus |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated